{"id":"NCT00973362","sponsor":"Gen-Probe, Incorporated","briefTitle":"Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System","officialTitle":"Clinical Evaluation of the APTIMA® HPV Assay on the TIGRIS® DTS® System in Women With ASC-US Pap Test Results and in Women 30 Years of Age or Older With Negative Pap Test Results Using ThinPrep Pap Test Specimens","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03","primaryCompletion":"2013-06","completion":"2014-04","firstPosted":"2009-09-09","resultsPosted":"2017-01-06","lastUpdate":"2017-01-06"},"enrollment":12896,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"SCREENING"},"conditions":["Human Papillomavirus Infection"],"interventions":[{"type":"DEVICE","name":"APTIMA HPV Assay","otherNames":[]},{"type":"DEVICE","name":"FDA-Approved HPV DNA Test","otherNames":[]}],"arms":[{"label":"Adjunct (i.e. Normal Pap)","type":"OTHER"},{"label":"ASC-US","type":"OTHER"}],"summary":"The purpose of this study is to provide data on the performance of the APTIMA HPV Assay using the TIGRIS System in detecting HPV types that may cause cervical cancer.","primaryOutcome":{"measure":"Adjunct Study Arm: Compare Assay Performance for Aptima HPV Assay to a FDA-Approved HPV Assay for Detecting CIN2+","timeFrame":"Baseline Evaluation","effectByArm":[{"arm":"APTIMA HPV Assay","deltaMin":15,"sd":null}],"pValues":[{"comp":"OG000","p":null},{"comp":"OG000","p":null},{"comp":"OG000","p":null},{"comp":"OG000","p":null},{"comp":"OG000","p":null},{"comp":"OG000","p":null}]},"eligibility":{"minAge":"21 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":17,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":11644},"commonTop":[]}}